CSE:ACOG - Post Discussion
Post by
stockpatrol on Feb 04, 2022 8:19pm
$ACOG.v / $ACOGF
According to $ACOG.v / $ACOGF ’s update on their corporate presentation NDA filing for their ALPHA-1062 drug, currently in stage3 development, in Q3.
https://www.alphacognition.com/_resources/presentations/corporate-presentation.pdf
Hopefully approval of ALPHA-1062 $ACOG.v will be swift, currently at $0.93 with a MC of $57M
Be the first to comment on this post